Detection performance remained consistent across sex and age, unlike the variability seen with AFP alone.
Pivotal DOORwaY90 trial evaluated Sirtex Medical’s Y90 selective internal radiation therapy to treat unresectable HCC.
Safety outcomes with tremelimumab (T) rechallenge in the phase 3 HIMALAYA study of T plus durvalumab (D) in unresectable hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology and embolization solutions, today announced landmark 12-month results from the DOORwaY90 study, the first pivotal, ...
Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
Clinicians in 5 states participated in an online survey to gauge the level of compliance with HCC surveillance guidelines. According to the survey, knowledge gaps and barriers to HCC screening in ...
The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ...
New study uncovers triplex-mediated transcriptional activation driving tumor suppression in HCC Hepatocellular carcinoma (HCC ...
Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results